STACY DAWKINS: Open Payments
NPI 1588673651 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $296 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $88 |
| Novo Nordisk Inc | 2 | $43 |
| Medtronic, Inc. | 1 | $30 |
| SCPHARMACEUTICALS INC. | 1 | $28 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $27 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Ozempic, CARDIOMEMS, LINQ II, FUROSCIX, LifeVest, PERCLOSE PROSTYLE, MITRACLIP, Attruby.
Industry payments across IN — which companies pay providers there.
